AI assistant
Sending…
ImmunityBio, Inc. — Director's Dealing 2020
Oct 29, 2020
31529_dirs_2020-10-29_01321e84-f846-4642-8259-764fab3a5964.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2020-10-26
Reporting Person: Adcock Richard (Chief Executive Officer)
More from ImmunityBio, Inc.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24